Parmax Pharma Limited is an Indian pharmaceutical company specializing in the manufacture of **Active Pharmaceutical Ingredients (APIs)**, **Drug Intermediates**, and **Specialty Chemicals**. Operating from its primary manufacturing hub in **Gujarat**, the company maintains a vertically integrated model that includes the production of finished oral formulations. Parmax is currently navigating a recovery phase following operational disruptions, focusing on high-volume therapeutic segments and cost-efficiency through modernized infrastructure. --- ### **Core Manufacturing Capabilities & Product Portfolio** The company operates within a **single business segment (Pharmaceuticals)**, with a diversified product basket catering to various therapeutic requirements. Its operations are centralized at a manufacturing facility in **Hadamtala, Rajkot (Gujarat)**, which is approved by the **CDSCO** and **State FDA** and adheres to **GMP-compliant** systems. * **Active Pharmaceutical Ingredients (APIs):** Focuses on Anti-infectives, Analgesics, Anti-inflammatory agents, and Cardiovascular drugs. * **Drug Intermediates & Specialty Chemicals:** Production of essential chemical building blocks for the pharmaceutical supply chain. * **Finished Formulations:** Manufacturing of general oral dosage forms, specifically **tablets and capsules**, for the domestic market. * **Quality Assurance:** While the company does not maintain a large-scale R&D wing, it conducts **ICH-guideline stability studies** and process optimization to improve yields and ensure the longevity of its product shelf-life. --- ### **Strategic Roadmap: FY 2025-26 Growth Pillars** Parmax is executing a transition toward high-volume therapeutic segments while aggressively optimizing its cost structure. The strategic focus for the upcoming fiscal years includes: * **Market Expansion:** Scaling the API business through new **B2B partnerships** within the Indian domestic market. * **Product Pipeline:** Plans to launch **2-3 new products** targeting high-demand therapeutic areas by **FY 2025-26**. * **Government Alignment:** Actively evaluating eligibility for the **Production Linked Incentive (PLI) scheme** to support large-scale manufacturing expansion. * **Operational Efficiency:** Investing in **energy-efficient utilities** and equipment upgrades to lower overheads and protect margins against fluctuating input costs. * **Governance Continuity:** Ensuring leadership stability with the re-appointment of key board members to the **Audit** and **Nomination Remuneration Committees** through **2028**. | Strategic Focus | Key Objective | Target Timeline | | :--- | :--- | :--- | | **New Product Launches** | **2-3 Products** in high-volume segments | **FY 2025-26** | | **Partnerships** | Domestic **B2B collaborations** for APIs | Ongoing | | **Operational Efficiency** | Cost reduction via **energy-efficient utilities** | Immediate | | **Government Schemes** | Evaluation of **PLI scheme** incentives | **FY 2025-26** | --- ### **Financial Profile & Capital Structure** As of **March 31, 2025**, the company maintains a lean balance sheet with no outstanding loans or third-party investments. However, financial performance has recently been impacted by an absence of surplus profits, leading to a **zero dividend distribution** policy for the period. **Key Financial Metrics (as of March 31, 2025):** * **Authorised Share Capital:** **Rs. 6.00 Crore** (60,00,000 shares) * **Paid-up Capital:** **Rs. 3.74 Crore** (37,41,300 shares) * **Cash and Cash Equivalents:** **Rs. 9.03 Lacs** * **Subsidiaries / Joint Ventures:** **Nil** * **Foreign Exchange Inflow (2024):** **USD 11,250** (Trade Receivables) * **Foreign Exchange Outflow (2024):** **USD 6,950** (Trade Payables) **Audit & Accounting Notes:** * **Insurance Provision:** A provision of **Rs. 3.5 Crores** has been recognized following a major fire incident. * **Depreciation Adjustments:** For the nine months ended **December 31, 2025**, depreciation was not charged on the **Clean Room Plant** and **Effluent Treatment Plant** due to non-usage. * **Write-offs:** The management wrote off **Rs. 39.61 Lakhs** in historical pre-operative expenses during **FY 2023-24**. --- ### **Operational Recovery & Asset Management** The company is currently managing the aftermath of a significant fire incident that occurred on **December 6, 2023**, at the Rajkot facility. This event damaged fixed assets, including the factory building and machinery. * **Insurance Status:** A formal claim of **Rs. 350 Lacs** is pending the final **Surveyor’s Report** as of February 2026. * **Energy Conservation:** A dedicated team is focused on resource optimization through: * Replacing legacy motors with **energy-efficient alternatives**. * Implementing **waste heat recovery** systems. * Evaluating **renewable energy sources** to reduce long-term utility costs. * **Utilization:** Despite the fire, the company reported **improved plant utilization** in Q3 and Q4 of FY25, successfully passing on higher input costs to customers. --- ### **Risk Factors & Regulatory Compliance** Investors should note several statutory non-compliances and operational uncertainties identified in recent audits. **1. Regulatory Contraventions (Companies Act, 2013):** * **Section 187(1):** An investment of **Rs. 40 Lakhs** in a Mutual Fund was held in the name of the **Managing Director** rather than the company. * **Sections 73-76:** The company accepted **Rs. 25 Lakhs** in deposits from relatives of Directors, which was flagged as a violation of **RBI directives** and the **Acceptance of Deposit Rules, 2015**. * **MSME Dues:** The company has not yet confirmed the status of its suppliers under the MSME Act, leaving potential dues unprovided for. **2. Audit Observations & Uncertainties:** * **Asset Verification:** Statutory auditors relied on management certification for fixed assets rather than independent physical verification. * **Financial Impact:** Due to a lack of collaborative documentation regarding fire-related asset loss, auditors could not fully verify the impact on the **Profit & Loss** statement. * **Contingent Liabilities:** The company carries **Rs. 1,00,00,000** in Bank Guarantees (as of FY23). **3. Statutory Frameworks:** The company operates under the oversight of the **SEBI (LODR) Regulations, 2015**, the **Environment (Protection) Act, 1986**, and various labor laws including the **Factories Act (1948)** and **Employees' Provident Fund Act (1952)**. Adherence to these frameworks is critical for maintaining its manufacturing licenses.